Author:
Stathopoulos G. P.,Tsavdaridis D.,Malamos N. A.,Rigatos S. K.,Kosmas Ch.,Pergantas N.,Stathopoulos J. G.,Xynotroulas J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference38 articles.
1. Nabholtz JM, Falkson C, Campos D et al (2003) Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter phase III trial. J Clin Oncol 21:968–975
2. A’Hern R, Smith I, Ebbs S (1993) Chemotherapy and survival in advanced breast cancer: the infusion of doxorubicin in Cooper type regimens. Br J Cancer 67:807–813
3. Weber BL, Vogel C, Jones S et al (1995) Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. J Clin Oncol 13:2722–2730
4. Gianni L, Munzone E, Capri G et al (1995) Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer. J Clin Oncol 13:2688–2699
5. Dombernowsky P, Gehl J, Boesgaard M et al (1995) Treatment of metastatic breast cancer with paclitaxel and doxorubicin. Semin Oncol 22(Suppl 15):13–16
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献